{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:56:19Z","timestamp":1787007379376,"version":"build-2736575974"},"reference-count":25,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2023,9,14]]},"DOI":"10.1080\/14737167.2023.2221436","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T01:43:29Z","timestamp":1685670209000},"page":"901-909","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-8233","authenticated-orcid":false,"given":"Xuanqian","family":"Xie","sequence":"first","affiliation":[{"name":"Health Technology Assessment Program, Ontario Health, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis K.","family":"Schaink","sequence":"additional","affiliation":[{"name":"Health Technology Assessment Program, Ontario Health, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, University of Regina, Regina, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-1641","authenticated-orcid":false,"given":"Olga","family":"Gajic-Veljanoski","sequence":"additional","affiliation":[{"name":"Health Technology Assessment Program, Ontario Health, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-0101","authenticated-orcid":false,"given":"Wendy J.","family":"Ungar","sequence":"additional","affiliation":[{"name":"Program of Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada"},{"name":"The Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9771-846X","authenticated-orcid":false,"given":"Andrei","family":"Volodin","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, University of Regina, Regina, SK, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"issue":"5","key":"e_1_3_8_3_1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober P","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018 May;126(5):1763\u20131768.","journal-title":"Anesth Analg"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000503"},{"issue":"3","key":"e_1_3_8_5_1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jval.2011.12.008","article-title":"Handling input correlations in pharmacoeconomic models","volume":"15","author":"Naversnik K","year":"2012","unstructured":"Naversnik K, Rojnik K. Handling input correlations in pharmacoeconomic models. Value Health. 2012 May;15(3):540\u2013549.","journal-title":"Value Health"},{"key":"e_1_3_8_6_1","first-page":"76","volume-title":"Guidelines for the economic evaluation of health technologies: Canada","author":"Canadian Agency for Drugs and Technologies in Health","year":"2017","unstructured":"Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 4th ed. Ottawa (ON): The Agency; 2017. p. 76.","edition":"4"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.04.014"},{"issue":"3","key":"e_1_3_8_8_1","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka MM","year":"2012","unstructured":"Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012 Sep;24(3):69\u201371.","journal-title":"Malawi Med J"},{"issue":"13","key":"e_1_3_8_9_1","first-page":"1","article-title":"Multi-gene pharmacogenomic testing that includes decision-support tools to guide medication selection for major depression: a health technology assessment","volume":"21","author":"Ontario Health","year":"2021","unstructured":"Ontario Health. Multi-gene pharmacogenomic testing that includes decision-support tools to guide medication selection for major depression: a health technology assessment. Ont Health Technol Assess Ser. 2021;21(13):1\u2013214.","journal-title":"Ont Health Technol Assess Ser"},{"key":"e_1_3_8_10_1","volume-title":"Simulating data with SAS","author":"Wicklin R","year":"2013","unstructured":"Wicklin R. Simulating data with SAS. Cary NC: SAS Institute Inc; 2013."},{"key":"e_1_3_8_11_1","unstructured":"R: a language and environment for statistical computing [Computer program]. Vienna: R Foundation for Statistical Computing; 2022."},{"key":"e_1_3_8_12_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"Briggs A","year":"2006","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford (UK): Oxford University Press; 2006."},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0162-0"},{"issue":"5","key":"e_1_3_8_14_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0706743719895342","article-title":"Economic burden of depression and associated resource use in Manitoba, Canada","volume":"65","author":"Tanner JA","year":"2020","unstructured":"Tanner JA, Hensel J, Davies PE, et al. Economic burden of depression and associated resource use in Manitoba, Canada. Can J Psychiatry. 2020 May;65(5):338\u2013346.","journal-title":"Can J Psychiatry"},{"issue":"5","key":"e_1_3_8_15_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jval.2011.02.001","article-title":"The impact of non-severe hypoglycemic events on work productivity and diabetes management","volume":"14","author":"Brod M","year":"2011","unstructured":"Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011 Jul;14(5):665\u2013671.","journal-title":"Value Health"},{"issue":"13","key":"e_1_3_8_16_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2217\/cer-2021-0059","article-title":"Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes","volume":"10","author":"Xie X","year":"2021","unstructured":"Xie X, Guo J, Bremner KE, et al. Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes. J Comp Eff Res. 2021 Sep;10(13):961\u2013974.","journal-title":"J Comp Eff Res"},{"issue":"6","key":"e_1_3_8_17_1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3111\/13696998.2015.1006730","article-title":"Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States","volume":"18","author":"Foos V","year":"2015","unstructured":"Foos V, Varol N, Curtis BH, et al. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ. 2015 Jun;18(6):420\u2013432.","journal-title":"J Med Econ"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2176"},{"issue":"4","key":"e_1_3_8_19_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14737167.2020.1779062","article-title":"An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health","volume":"20","author":"Lugner AK","year":"2020","unstructured":"Lugner AK, Krabbe PFM. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):331\u2013342.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"10","key":"e_1_3_8_20_1","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s11136-013-0401-1","article-title":"A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada","volume":"22","author":"Krahn MD","year":"2013","unstructured":"Krahn MD, Bremner KE, Alibhai SM, et al. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada. Qual Life Res. 2013 Dec;22(10):2951\u20132962.","journal-title":"Qual Life Res"},{"issue":"3","key":"e_1_3_8_21_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00592-018-1244-6","article-title":"Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L","volume":"56","author":"Takahara M","year":"2019","unstructured":"Takahara M, Katakami N, Shiraiwa T, et al. Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L. Acta Diabetol. 2019 Mar;56(3):309\u2013319.","journal-title":"Acta Diabetol"},{"issue":"1","key":"e_1_3_8_22_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin NJ","year":"2018","unstructured":"Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018 Jan;27(1):7\u201322.","journal-title":"Health Econ"},{"issue":"8","key":"e_1_3_8_23_1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard AS","year":"2019","unstructured":"Pickard AS, Law EH, Jiang R, et al. United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 2019 Aug;22(8):931\u2013941.","journal-title":"Value Health"},{"issue":"8","key":"e_1_3_8_24_1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/0272989X16658660","article-title":"The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes","volume":"36","author":"Peasgood T","year":"2016","unstructured":"Peasgood T, Brennan A, Mansell P, et al. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making. 2016 Nov;36(8):1020\u20131033.","journal-title":"Med Decis Making"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21706-2"},{"issue":"3","key":"e_1_3_8_26_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s41669-019-00188-5","article-title":"Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA RCT","volume":"4","author":"Hollingworth W","year":"2020","unstructured":"Hollingworth W, Fawsitt CG, Dixon P, et al. Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA RCT. Pharmacoecon Open. 2020 Sep;4(3):427\u2013438.","journal-title":"Pharmacoecon Open"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2019.1615886"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2023.2221436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T10:32:58Z","timestamp":1702549978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2023.2221436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,9,14]]}},"alternative-id":["10.1080\/14737167.2023.2221436"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2023.2221436","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}